Aptamer Sciences Announces 2-to-1 Stock Consolidation to Improve Stock Price and Enhance Corporate Value, Limited Impact on Shareholder Value
Aptamer Sciences has decided on a 2-to-1 stock consolidation, merging two common shares into one. This changes the par value from 500 won to 1,000 won and reduces total common shares from 61,039,242 to 30,519,621. The purpose is to form an appropriate stock price and enhance corporate value, and it is not a capital reduction.
The new shares will be effective on July 24, 2026, with trading suspended from July 22 to August 11, 2026. Fractional shares less than one share will be paid in cash based on the closing price on the first listing day of the new shares. The board resolution was made on June 23, 2026, and approval from an extraordinary general meeting of shareholders is required.
The stock consolidation reduces the number of shares without changing existing shareholders' ownership percentages, so the per-share price is expected to rise proportionally. Short-term price volatility may occur, but the long-term impact depends on whether the goal of enhancing corporate value is achieved.
[AI Summary]Aptamer Sciences' stock consolidation is a structural adjustment that only reduces share count without capital changes, causing no dilution for existing shareholders. It aims to address undervaluation and improve price stability, but since no fundamental corporate value change occurs, the impact on shareholder value is neutral.